Log In
Print
BCIQ
Print
Print this Print this
 

CNTO 3157

  Manage Alerts
Collapse Summary General Information
Company Johnson & Johnson
DescriptionHuman HuCAL antibody
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase II
Standard IndicationAsthma
Indication DetailsTreat asthma
Regulatory Designation
Partner MorphoSys AG

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today